Sinovac Biotech, a China-based vaccine manufacturer, has announced that its subsidiary, Sinovac Beijing, has completed its acquisition of buildings and land use rights for an extension of its production capacity.

Sinovac Biotech, a developer and provider of vaccines in China, has received a certificate of approval from the Secretaria de Salud to distribute PANFLU.1, its H1N1 pandemic influenza (swine flu) vaccine, in Mexico.

Sinovac Biotech, a Chinese provider of biopharmaceutical products, has signed an agreement with Boryung Pharmaceutical Company, a Korean manufacturer of pharmaceuticals, to collaborate on marketing efforts and possible H1N1 vaccine supply to the South Korean government.

Bridge Laboratories has announced that it has reached an agreement to build its second preclinical facility in China.

With Wanglaoji Herbal Tea as the major source of its profits, Guangzhou Wanglaoji Pharmaceutical Company realized a sales increase of 40% in the first quarter of 2008.

A project for producing inactivated rabies animal vaccines was recently launched in Changzhou National High-tech District in Jiangsu Province.